WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

The Biologic Basis of Hernia Formation

Completed

Conditions: Hiatal Hernia
Paraesophageal Hernia

First Posted Date: 2010-04-06

Last Posted Date: 2018-05-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 151

Registration Number: NCT01099033

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy

Completed

Conditions: Duchenne Muscular Dystrophy

First Posted Date: 2010-04-05

Last Posted Date: 2017-01-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT01098708

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

Brain, Obesity, Dopamine and You Study

Not Applicable

Completed

Conditions: Obesity

Interventions: Dietary Supplement: meal replacements, psychotherapy, dietary education

First Posted Date: 2010-03-29

Last Posted Date: 2016-11-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 82

Registration Number: NCT01094756

Locations: 🇺🇸
Washington University Medical School, St. Louis, Missouri, United States

Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV

Phase 2

Completed

Conditions: Diabetes
Insulin Resistance

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2010-03-26

Last Posted Date: 2014-02-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01093651

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: Pazopanib

First Posted Date: 2010-03-04

Last Posted Date: 2015-06-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT01080248

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

A Randomized Prospective Trial of Total Knee Arthroplasty Options Comparing Standard Knee Cutting Guides and MRI Generated Patient Specific Custom Cutting Guides

Not Applicable

Completed

Conditions: Osteoarthritis of the Knee

Interventions: Other: Instrument

First Posted Date: 2010-02-19

Last Posted Date: 2018-06-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT01072019

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery

Completed

Conditions: Cardiomyopathy

First Posted Date: 2010-02-11

Last Posted Date: 2024-01-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT01067209

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

iNOS With Positron Emission Tomography (PET) in Cellular Inflammation.

Early Phase 1

Completed

Conditions: Patients With Post Orthotopic Heart Transplantation Status

Interventions: Drug: [18F](+/-)NOS

First Posted Date: 2010-02-10

Last Posted Date: 2020-08-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT01066637

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)

Phase 1

Completed

Conditions: Myelodysplastic Syndromes

Interventions: Drug: G-CSF
Drug: Plerixafor
Drug: Azacitidine

First Posted Date: 2010-02-09

Last Posted Date: 2017-03-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 28

Registration Number: NCT01065129

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

Phase 1

Active, not recruiting

Conditions: Carcinoma

Interventions: Drug: Intraperitoneal Oxaliplatin
Drug: Bevacizumab
Drug: Capecitabine

First Posted Date: 2010-02-03

Last Posted Date: 2024-11-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01061515

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy